Navigation Links
StemCyte Launches New Website
Date:12/7/2010

COVINA, Calif., Dec. 7, 2010 /PRNewswire/ -- California-based StemCyte, Inc. announces the launching of its new website, www.StemCyte.com, a comprehensive resource on cord blood banking and its transplant and research initiatives.  In an effort to provide the most comprehensive source of cord blood banking information and education online, StemCyte's new website includes extensive information for customers, physicians, and the general public on the lifesaving medical resource of umbilical cord blood stem cells as well as the potential for regenerative medicine.  

After robust feedback from physicians, clients, researchers and expecting parents during the past year, StemCyte reconstructed its website to provide the quickest and most efficient educational guide to learning about the science and promise of cord blood banking. Free information kits and educational videos are also available to interested parties at www.StemCyte.com.

"As one of the world's preeminent cord blood banks and biotherapy companies, we are pleased to offer this critical information and communication tool to our global audience," said Calvin Cole, StemCyte's President, North America.  "We are committed to making available timely and accurate information regarding public and private cord blood banking options, updates on existing therapies and the latest information on cutting-edge biotherapy research."

This website represents StemCyte's latest effort to enhance awareness regarding the science and promise of umbilical cord blood banking and related medical research.

About StemCyte, Inc.

Located in the US, India and Taiwan, StemCyte has established one of the largest, most racially diverse, and highest quality cord blood stem cell banks in the world.  StemCyte has supplied over 1,300 cord blood products for over 70 life-threatening diseases to over 200 leading worldwide transplant centers.  StemCyte is actively involved in the development of new umbilical cord blood-based cell therapies.  They are supporting the largest clinical study for using unrelated cord blood transplantation for thalassemia, one of the most common genetic diseases in the world, and supporting the developments of trials investigating regenerative spinal cord therapies.  They are the only for-profit company contracted by the US Department of HHS to establish a public National Cord Blood Inventory for unrelated transplant units.  Its headquarters are located in Covina, Ca. and Ewing, NJ.  To learn more visit www.StemCyte.com.


'/>"/>
SOURCE StemCyte, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. StemCyte Awarded $488,950 for Advanced Therapeutic Applications of Umbilical Cord Blood Stem Cells from the Qualifying Therapeutic Discovery Project (QTDP)
2. 7-Time Olympic Medalist Shannon Miller Endorses StemCyte
3. Wiley-VCH launches new journal Advanced Energy Materials
4. HIPAA 5010 Ready: DST Health Solutions Launches Upgrades of Amisys Advance, PowerMHS, PowerMHC and PowerSTEPP
5. National Science Foundation launches "Innovation Nation"
6. Pfenex Inc. Launches reagentproteins.com
7. Adaptive TCR Launches the immunoSEQ™ Product Line - Visualizing the Immune System With Next-Generation Sequencing.
8. Prometheus Research Launches Solutions Group to Springboard HTSQL-based Solutions for Customers
9. Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinsons Disease
10. CoreLab Partners Launches New DXA Imaging Service Offerings
11. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... FRANCISCO , Feb. 23, 2017   ViaCyte, ... Type 1, a not-for-profit advocacy and education group for ... grant from Beyond Type 1 to support ViaCyte,s efforts ... other insulin-requiring diabetes.  For more than ... cell replacement therapies with a focus on the treatment ...
(Date:2/22/2017)... Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. announced today ... at the Annual Biocom Global Life Science Partnering Conference.  ... 11:15 AM, at the Torrey Pines Lodge, in San ... organizers at Biocom who have chosen our company, amongst ... biotechnology companies, investors, and clinical researchers," said Mr. Chen. ...
(Date:2/22/2017)... ... ... LabRoots , the leading provider of educational and interactive virtual events ... the launch of a new scholarship for young scientists seeking a degree in any ... open to all high school seniors, 17 years or older; as well as those ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pharma and ... Perkins as European director. Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. ... joins Pennside after more than a decade with leading market research firm, GfK. ...
Breaking Biology Technology:
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
Breaking Biology News(10 mins):